Abstract:An appropriate conventional method has been utilised to synthesise new tridentate Schiff base ligand 4-chloro-2-((2,4-dihydroxybenzylidene)amino)benzoic acid with Co (II), Ni (II), Cu (II), and Zn (II) complexes. Several spectroscopic(FT-IR, 1 H NMR, 13 C NMR, UV–Vis, Mass), TGA-DTA, powder X-ray diffraction, and DFT calculations, were used to characterise these complexes.According to these spectroscopic investigations, the ligand coordinated with the metals via carboxylic oxygen, azomethine nitrogen, and hydroxyl oxygen, acting as a tridentate ligand. Appropriate geometry for every complex has been proposed based on spectroscopic and analytical data. In tetrahedral geometry with Co(II), Ni(II), Zn(II), and square planner with Cu(II) ion, the ligand functions as a tridentate via ONO donors.The optimal structure (bond length and bond angle) and chemical reactivity of the ligand and its metal complexes from their Frontier Molecular Orbitals (FMO) and Molecular electrostatic potential (MESP) calculations have been investigated using Density Functional Theory (DFT/B3LYP,6-31G**/6-311G**(d,p), and LanL2DZ basis sets) calculations. In vitro DPPH radical scavenging techniques were used to assess the antioxidant activity of the ligand and its metal complexes. The results indicated that all of the complexes exhibited good antioxidant activity, with Cu (II) complex being the most potent with the lowest IC 50 values.The ligand and complexes' in vitro antibacterial activities were further explored by screening them against Gram(+ve) bacteria (Bacillus subtilis) and Gram(−ve) bacteria (E. coli) . Significant activity was demonstrated by all synthesised compounds against the tested strains of bacteria. The antifungal activity of complexes against Aspergillus niger and Candida albicans was determined. The results indicated that Cu (II) complex exhibited good antifungal activity against Candida albicans , but not against Aspergillus niger . The fungal strain Aspergillus niger was not significantly inhibited by complexes. The complexes have greater antimicrobial activity than the Schiff base ligand, as indicated by the MIC values.

New Complexes with Triazole Schiff Bases Derivative Ligand Containing Aspirin: Synthesis, Structure, Conductivity and Magnetic Susceptibility

Synthesis and Characterization of New Schiff Base Containing 1,2,4-Triazole-3-thione Moiety and Its Complexes with Some Transition Metal Ions: Spectroscopic and Computational Studies

Synthesis, spectro-themal characterization, DFT calculations and biochemical evaluation of a newly synthesized tridentate Schiff base transition metal complexes

Synthesis, Crystal Structures, HF-EPR, and Magnetic Properties of Six-Coordinate Transition Metal (co, Ni, and Cu) Compounds with a 4-Amino-1,2,4-triazole Schiff-base Ligand.

Copper(II), nickel(II), zinc(II) and cadmium(II) complexes of 1,2,4-triazole based Schiff base ligand: synthesis, comparative spectroscopic, thermal, biological and molecular docking studies

Synthesis, Characterization, Investigation of DNA Interactions and Biological Evaluation of Co(II), Ni(II), Cu(II) and Zn(II) Complexes with Newly Synthesized 2-methoxy 5-trifluoromethyl benzenamine Schiff Base

Synthesis, Characterization and in Vitro Biological Activity of Cobalt(ii), Copper(ii) and Zinc(ii) Schiff Base Complexes Derived from Salicylaldehyde and D,L‐selenomethionine

Synthesis, characterization, crystal structure and magnetic properties of dissymmetrical doub'e Schiff base heterotrinuclear complexes with N-3-carboxylsalicylidene-N'-salicylidene-1,3-propylenediamine trivalent anions

Syntheses, Characterization and Biological Studies of Zinc(ii), Copper(ii) and Cobalt(ii) Complexes with Schiff Base Ligand Derived from 2‐hydroxy‐1‐naphthaldehyde and Selenomethionine

Preparation, Characterization, DFT Calculations, Antibacterial and Molecular Docking Study of Co(II), Cu(II), and Zn(II) Mixed Ligand Complexes

Synthesis, characterization, crystal structure and magnetic property of asymmetrical double Schiff base heterotrinuclear complex: Cu(II)–Co(II)–Cu(II)

Synthesis, Characterization, DNA Cleavage, and Antimicrobial Studies of Some Transition Metal Complexes With a Novel Schiff Base Derived From 2-Aminopyrimidine

Syntheses and Structures of Mononuclear and Binuclear Transition Metal Complexes (cu, Zn, Ni) with (salicylideneglycine and Imidazole)

(Schiff-base)CuII Complexes with Phenolate-Oxygen/Chloro or -Oxygen/Azido Mixed Bridges ? Syntheses, Crystal Structures and Magnetic Properties

DESIGN, SYNTHESIS AND BIOLOGICAL PROPERTIES OF TRANSITION METAL COMPLEXES OF SCHIFF BASE LIGAND DERIVED FROM PYRIDINE DERIVATIVES

Synthesis, Crystal Structures, and Magnetic Properties of Tetranuclear Nickel(Ii) and Copper(Ii) Complexes with Tridentate Schiff Bases

Synthesis, Crystal Structure, Hirshfeld Surfaces, and Spectral Properties of Cu(II) and Co(II) Complexes with 3-Phenoxymethyl-4-phenyl-5-(2-pyridyl)-1,2,4-triazole

Three Co(II), Ni(II) and Cu(II) Schiff base complexes incorporating 2-[(4-{[(4-methylphenyl)sulfonothioyl]oxy}phenyl)methylene] amino}benzoic acid: Synthesis, structural, dft, biological and molecular docking investigation

Synthesis, X-ray structure and magnetic properties of trinuclear copper(II) tridentate Schiff base complexes containing a partial cubane Cu3O4 core

Synthesis, Structures, and Magnetic Properties of the Copper(ii), Cobalt(ii), and Manganese(ii) Complexes with 9-Acridinecarboxylate and 4-Quinolinecarboxylate Ligands.

Design, Synthesis, Structural Investigation and Photo Induced Biological Investigations of Co(II), Ni(II) and Cu(II) Complexes Derived from N,O Donor Schiff Bases